BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18202164)

  • 1. Population based epidemiology and prognosis of mesothelioma in Leeds, UK.
    Chapman A; Mulrennan S; Ladd B; Muers MF
    Thorax; 2008 May; 63(5):435-9. PubMed ID: 18202164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant mesothelioma of the pleura].
    Erika V; Zoltán S; Miklós Z; Judit A; Akos L; Kálmán K
    Orv Hetil; 1996 Feb; 137(5):233-8. PubMed ID: 8882441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.
    Sugarbaker DJ; Heher EC; Lee TH; Couper G; Mentzer S; Corson JM; Collins JJ; Shemin R; Pugatch R; Weissman L
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):10-4; discussion 14-5. PubMed ID: 2072707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment results of 17 patients with diffuse pleural mesothelioma.
    Liu CC; Hsu WH; Li WY; Huang MH
    Ann Thorac Cardiovasc Surg; 1998 Oct; 4(5):233-9. PubMed ID: 9828278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathology associated with therapeutic procedures in malignant mesothelioma.
    Attanoos RL; Gibbs AR
    Histopathology; 2004 Oct; 45(4):393-7. PubMed ID: 15469478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma.
    O'Rourke N; Garcia JC; Paul J; Lawless C; McMenemin R; Hill J
    Radiother Oncol; 2007 Jul; 84(1):18-22. PubMed ID: 17588698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
    Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
    Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life after first-line chemotherapy in malignant pleural mesothelioma: a North-East England experience.
    Steer J; Bough G; Razak AR; Meachery GJ; Hughes A
    Clin Oncol (R Coll Radiol); 2010 Apr; 22(3):231-5. PubMed ID: 20346340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma.
    Di Salvo M; Gambaro G; Pagella S; Manfredda I; Casadio C; Krengli M
    Acta Oncol; 2008; 47(6):1094-8. PubMed ID: 18770063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital.
    Huncharek M; Kelsey K; Mark EJ; Muscat J; Choi N; Carey R; Christiani D
    Anticancer Res; 1996; 16(3A):1265-8. PubMed ID: 8702248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant pleural mesothelioma].
    Kawamata O; Kondu Y; Murata T; Uetsuka H; Uda M; Nakai H; Ohta T
    Kyobu Geka; 2007 Jan; 60(1):31-4. PubMed ID: 17249535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Needle-track metastases and prophylactic radiotherapy for mesothelioma.
    West SD; Foord T; Davies RJ
    Respir Med; 2006 Jun; 100(6):1037-40. PubMed ID: 16266800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
    Aelony Y; Yao JF
    Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.